Science 19 December 1986: Vol. 234. no. 4783, pp. 1563 - 1566 DOI: 10.1126/science.2431484

Prev | Table of Contents | Next

Articles

The Quality of Chimpanzee T-Cell Activation and Simian Immunodeficiency Virus/Human Immunodeficiency Virus Susceptibility Achieved via Antibody-Mediated T-Cell Receptor/CD3 Stimulation Is a Function of the Anti-CD3 Antibody Isotype.

F. Bibollet-Ruche, B. A. McKinney, A. Duverger, F. H. Wagner, A. A. Ansari, and O. Kutsch (2008)
J. Virol. 82, 10271-10278
 |  Abstract »  |  Full Text »  |  PDF »

HIV-Induced Changes in T Cell Signaling Pathways.

M. Schweneker, D. Favre, J. N. Martin, S. G. Deeks, and J. M. McCune (2008)
J. Immunol. 180, 6490-6500
 |  Abstract »  |  Full Text »  |  PDF »

Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge.

P. Sen, W. A. Charini, R. A. Subbramanian, E. R. Manuel, M. J. Kuroda, P. A. Autissier, and N. L. Letvin (2008)
J. Virol. 82, 805-816
 |  Abstract »  |  Full Text »  |  PDF »

SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.

C. Petrovas, D. A. Price, J. Mattapallil, D. R. Ambrozak, C. Geldmacher, V. Cecchinato, M. Vaccari, E. Tryniszewska, E. Gostick, M. Roederer, et al. (2007)
Blood 110, 928-936
 |  Abstract »  |  Full Text »  |  PDF »

Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression.

A. Crotti, M. Lusic, R. Lupo, P. M. J. Lievens, E. Liboi, G. D. Chiara, M. Tinelli, A. Lazzarin, B. K. Patterson, M. Giacca, et al. (2007)
Blood 109, 5380-5389
 |  Abstract »  |  Full Text »  |  PDF »

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes.

L. Bozzacco, C. Trumpfheller, F. P. Siegal, S. Mehandru, M. Markowitz, M. Carrington, M. C. Nussenzweig, A. G. Piperno, and R. M. Steinman (2007)
PNAS 104, 1289-1294
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes..

N. Goonetilleke, S. Moore, L. Dally, N. Winstone, I. Cebere, A. Mahmoud, S. Pinheiro, G. Gillespie, D. Brown, V. Loach, et al. (2006)
J. Virol. 80, 4717-4728
 |  Abstract »  |  Full Text »  |  PDF »

HIV Pathogenesis: Knowledge Gained after Two Decades of Research.

J.A. Levy (2006)
Advances in Dental Research 19, 10-16
 |  Abstract »  |  Full Text »  |  PDF »

Innate and Adaptive Mucosal Immunity in Protection against HIV Infection.

L.A. Bergmeier and T. Lehner (2006)
Advances in Dental Research 19, 21-28
 |  Abstract »  |  Full Text »  |  PDF »

Suppression of MIP-1{beta} transcription in human T cells is regulated by inducible cAMP early repressor (ICER).

O. Barabitskaja, J. S. Foulke Jr., S. Pati, J. Bodor, and M. S. Reitz Jr. (2006)
J. Leukoc. Biol. 79, 378-387
 |  Abstract »  |  Full Text »  |  PDF »

Changes in Soluble Factor-Mediated CD8+ Cell-Derived Antiviral Activity in Cynomolgus Macaques Infected with Simian Immunodeficiency Virus SIVmac251: Relationship to Biological Markers of Progression.

V. Dioszeghy, K. Benlhassan-Chahour, B. Delache, N. Dereuddre-Bosquet, C. Aubenque, G. Gras, R. Le Grand, and B. Vaslin (2006)
J. Virol. 80, 236-245
 |  Abstract »  |  Full Text »  |  PDF »

Immunodomination in the Evolution of Dominant Epitope-Specific CD8+ T Lymphocyte Responses in Simian Immunodeficiency Virus-Infected Rhesus Monkeys.

M. H. Newberg, K. J. McEvers, D. A. Gorgone, M. A. Lifton, S. H. C. Baumeister, R. S. Veazey, J. E. Schmitz, and N. L. Letvin (2006)
J. Immunol. 176, 319-328
 |  Abstract »  |  Full Text »  |  PDF »

Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells.

X. Wang, N. Tan, S. D. Douglas, T. Zhang, Y.-J. Wang, and W.-Z. Ho (2005)
J. Leukoc. Biol. 78, 772-776
 |  Abstract »  |  Full Text »  |  PDF »

In Vitro Suppression of Human Immunodeficiency Virus Type 1 Replication by Measles Virus.

M. Garcia, X.-F. Yu, D. E. Griffin, and W. J. Moss (2005)
J. Virol. 79, 9197-9205
 |  Abstract »  |  Full Text »  |  PDF »

Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses.

U. Wille-Reece, C.-y. Wu, B. J. Flynn, R. M. Kedl, and R. A. Seder (2005)
J. Immunol. 174, 7676-7683
 |  Abstract »  |  Full Text »  |  PDF »

Cellular immune selection with hepatitis C virus persistence in humans.

A. L. Cox, T. Mosbruger, Q. Mao, Z. Liu, X.-H. Wang, H.-C. Yang, J. Sidney, A. Sette, D. Pardoll, D. L. Thomas, et al. (2005)
J. Exp. Med. 201, 1741-1752
 |  Abstract »  |  Full Text »  |  PDF »

Human Immunodeficiency Virus Type 1 Gag-Specific Mucosal Immunity after Oral Immunization with Papillomavirus Pseudoviruses Encoding Gag.

H. Zhang, R. Fayad, X. Wang, D. Quinn, and L. Qiao (2004)
J. Virol. 78, 10249-10257
 |  Abstract »  |  Full Text »  |  PDF »

Nef Stimulates Human Immunodeficiency Virus Type 1 Replication in Primary T Cells by Enhancing Virion-Associated gp120 Levels: Coreceptor-Dependent Requirement for Nef in Viral Replication.

C. A. Lundquist, J. Zhou, and C. Aiken (2004)
J. Virol. 78, 6287-6296
 |  Abstract »  |  Full Text »  |  PDF »

High Beta-Chemokine Expression Levels in Lymphoid Tissues of Simian/Human Immunodeficiency Virus 89.6-Vaccinated Rhesus Macaques Are Associated with Uncontrolled Replication of Simian Immunodeficiency Virus Challenge Inoculum.

L. LaFranco-Scheuch, K. Abel, N. Makori, K. Rothaeusler, and C. J. Miller (2004)
J. Virol. 78, 6399-6408
 |  Abstract »  |  Full Text »  |  PDF »

Mycobacterium tuberculosis Recall Antigens Suppress HIV-1 Replication in Anergic Donor Cells via CD8+ T Cell Expansion and Increased IL-10 Levels.

S. Ranjbar, N. Ly, S. Thim, J.-M. Reynes, and A. E. Goldfeld (2004)
J. Immunol. 172, 1953-1959
 |  Abstract »  |  Full Text »  |  PDF »

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.

S. F. Abdelwahab, F. Cocchi, K. C. Bagley, R. Kamin-Lewis, R. C. Gallo, A. DeVico, and G. K. Lewis (2003)
PNAS 100, 15006-15010
 |  Abstract »  |  Full Text »  |  PDF »

The Trojan exosome hypothesis.

S. J. Gould, A. M. Booth, and J. E. K. Hildreth (2003)
PNAS 100, 10592-10597
 |  Abstract »  |  Full Text »  |  PDF »

Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte Responses.

D. H. O'Connor, B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, et al. (2003)
J. Virol. 77, 9029-9040
 |  Abstract »  |  Full Text »  |  PDF »

Adaptation in the env Gene of HIV-1 and Evolutionary Theories of Disease Progression.

S. Williamson (2003)
Mol. Biol. Evol. 20, 1318-1325
 |  Abstract »  |  Full Text »  |  PDF »

CAF-Mediated Human Immunodeficiency Virus (HIV) Type 1 Transcriptional Inhibition Is Distinct from {alpha}-Defensin-1 HIV Inhibition.

T. L.-Y. Chang, F. Francois, A. Mosoian, and M. E. Klotman (2003)
J. Virol. 77, 6777-6784
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-7-Dependent Production of RANTES That Correlates with Human Immunodeficiency Virus Disease Progression.

A. Llano, J. Barretina, A. Gutierrez, B. Clotet, and J. A. Este (2003)
J. Virol. 77, 4389-4395
 |  Abstract »  |  Full Text »  |  PDF »

The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

C. E. Mackewicz, C. S. Craik, and J. A. Levy (2003)
PNAS 100, 3433-3438
 |  Abstract »  |  Full Text »  |  PDF »

Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses.

K. Abel, L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Bost, and C. J. Miller (2003)
J. Virol. 77, 3099-3118
 |  Abstract »  |  Full Text »  |  PDF »

Peripheral Blood Cytotoxic {gamma}{delta} T Lymphocytes from Patients with Human Immunodeficiency Virus Type 1 Infection and AIDS Lyse Uninfected CD4+ T Cells, and Their Cytocidal Potential Correlates with Viral Load.

S. T. A. K. Sindhu, R. Ahmad, R. Morisset, A. Ahmad, and J. Menezes (2003)
J. Virol. 77, 1848-1855
 |  Abstract »  |  Full Text »  |  PDF »

HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin Family.

R. Geiben-Lynn, M. Kursar, N. V. Brown, M. M. Addo, H. Shau, J. Lieberman, A. D. Luster, and B. D. Walker (2003)
J. Biol. Chem. 278, 1569-1574
 |  Abstract »  |  Full Text »  |  PDF »

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

D. Zhang, P. Shankar, Z. Xu, B. Harnisch, G. Chen, C. Lange, S. J. Lee, H. Valdez, M. M. Lederman, and J. Lieberman (2003)
Blood 101, 226-235
 |  Abstract »  |  Full Text »  |  PDF »

Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection.

V. Novitsky, P. Gilbert, T. Peter, M. F. McLane, S. Gaolekwe, N. Rybak, I. Thior, T. Ndung'u, R. Marlink, T. H. Lee, et al. (2002)
J. Virol. 77, 882-890
 |  Abstract »  |  Full Text »  |  PDF »

Lymphoid Interstitial Pneumonia: A Narrative Review.

J. J. Swigris, G. J. Berry, T. A. Raffin, and W. G. Kuschner (2002)
Chest 122, 2150-2164
 |  Abstract »  |  Full Text »  |  PDF »

Contribution of Human alpha -Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor.

L. Zhang, W. Yu, T. He, J. Yu, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. J. Ho, et al. (2002)
Science 298, 995-1000
 |  Abstract »  |  Full Text »  |  PDF »

Purification of a Modified Form of Bovine Antithrombin III as an HIV-1 CD8+ T-cell Antiviral Factor.

R. Geiben-Lynn, N. Brown, B. D. Walker, and A. D. Luster (2002)
J. Biol. Chem. 277, 42352-42357
 |  Abstract »  |  Full Text »  |  PDF »

Elicitation of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Mucosal Compartments of Rhesus Monkeys by Systemic Vaccination.

J. Baig, D. B. Levy, P. F. McKay, J. E. Schmitz, S. Santra, R. A. Subbramanian, M. J. Kuroda, M. A. Lifton, D. A. Gorgone, L. S. Wyatt, et al. (2002)
J. Virol. 76, 11484-11490
 |  Abstract »  |  Full Text »  |  PDF »

Immune-Mediated Positive Selection Drives Human Immunodeficiency Virus Type 1 Molecular Variation and Predicts Disease Duration.

H. A. Ross and A. G. Rodrigo (2002)
J. Virol. 76, 11715-11720
 |  Abstract »  |  Full Text »  |  PDF »

Interferon-{alpha} as an immunotherapeutic protein.

D. L. Brassard, M. J. Grace, and R. W. Bordens (2002)
J. Leukoc. Biol. 71, 565-581
 |  Abstract »  |  Full Text »  |  PDF »

A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation.

T. L.-Y. Chang, A. Mosoian, R. Pine, M. E. Klotman, and J. P. Moore (2002)
J. Virol. 76, 569-581
 |  Abstract »  |  Full Text »  |  PDF »

A Commonly Recognized Simian Immunodeficiency Virus Nef Epitope Presented to Cytotoxic T Lymphocytes of Indian-Origin Rhesus Monkeys by the Prevalent Major Histocompatibility Complex Class I Allele Mamu-A*02.

S. Robinson, W. A. Charini, M. H. Newberg, M. J. Kuroda, C. I. Lord, and N. L. Letvin (2001)
J. Virol. 75, 10179-10186
 |  Abstract »  |  Full Text »  |  PDF »

Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

J. Lieberman, P. Shankar, N. Manjunath, and J. Andersson (2001)
Blood 98, 1667-1677
 |  Abstract »  |  Full Text »  |  PDF »

Noncytolytic Inhibition of X4 Virus by Bulk CD8+ Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Persons and HIV-1-Specific Cytotoxic T Lymphocytes Is Not Mediated by {beta}-Chemokines.

R. Geiben-Lynn, M. Kursar, N. V. Brown, E. L. Kerr, A. D. Luster, and B. D. Walker (2001)
J. Virol. 75, 8306-8316
 |  Abstract »  |  Full Text »  |  PDF »

Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites.

A. A. Horner, S. K. Datta, K. Takabayashi, I. M. Belyakov, T. Hayashi, N. Cinman, M.-D. Nguyen, J. H. Van Uden, J. A. Berzofsky, D. D. Richman, et al. (2001)
J. Immunol. 167, 1584-1591
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus Macaques.

D. C. Montefiori, J. T. Safrit, S. L. Lydy, A. P. Barry, M. Bilska, H. T. T. Vo, M. Klein, J. Tartaglia, H. L. Robinson, and B. Rovinski (2001)
J. Virol. 75, 5879-5890
 |  Abstract »  |  Full Text »  |  PDF »

Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics.

C. M. Hogan and S. M. Hammer (2001)
Ann Intern Med 134, 978-996
 |  Abstract »  |  Full Text »  |  PDF »

HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients.

A. Hosmalin, A. Samri, M.-J. Dumaurier, Y. Dudoit, E. Oksenhendler, M. Karmochkine, B. Autran, S. Wain-Hobson, and R. Cheynier (2001)
Blood 97, 2695-2701
 |  Abstract »  |  Full Text »  |  PDF »

CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing.

T. M. Allen, B. R. Mothé, J. Sidney, P. Jing, J. L. Dzuris, M. E. Liebl, T. U. Vogel, D. H. O'Connor, X. Wang, M. C. Wussow, et al. (2001)
J. Virol. 75, 738-749
 |  Abstract »  |  Full Text »

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: Implications for the development of therapeutic strategies.

T.-W. Chun, J. S. Justement, S. Moir, C. W. Hallahan, L. A. Ehler, S. Liu, M. McLaughlin, M. Dybul, J. M. Mican, and A. S. Fauci (2001)
PNAS 98, 253-258
 |  Abstract »  |  Full Text »  |  PDF »

Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1{alpha}, and MCP-3, and enhancement by MCP-1.

E. Vicenzi, M. Alfano, S. Ghezzi, A. Gatti, F. Veglia, A. Lazzarin, S. Sozzani, A. Mantovani, and G. Poli (2000)
J. Leukoc. Biol. 68, 405-412
 |  Abstract »  |  Full Text »  |  PDF »

Class I-unrestricted noncytotoxic anti-HTLV-I activity of CD8+ T cells.

M. Moriuchi and H. Moriuchi (2000)
Blood 96, 1994-1995
 |  Abstract »  |  Full Text »  |  PDF »

Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape.

A. K. Sewell, D. A. Price, A. Oxenius, A. D. Kelleher, and R. E. Phillips (2000)
Stem Cells 18, 230-244
 |  Abstract »  |  Full Text »

In vitro correlates of HIV-2-mediated HIV-1 protection.

E. G. Kokkotou, J.-L. Sankale, I. Mani, A. Gueye-Ndiaye, D. Schwartz, M. E. Essex, S. Mboup, and P. J. Kanki (2000)
PNAS 97, 6797-6802
 |  Abstract »  |  Full Text »  |  PDF »

CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription.

S. Le Borgne, M. Février, C. Callebaut, S. P. Lee, and Y. Rivière (2000)
J. Virol. 74, 4456-4464
 |  Abstract »  |  Full Text »

Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus Stimulation.

L. A. Pinto, V. Blazevic, B. K. Patterson, C. Mac Trubey, M. J. Dolan, and G. M. Shearer (2000)
J. Virol. 74, 4505-4511
 |  Abstract »  |  Full Text »

CD8+ cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.

C. E. Mackewicz, B. K. Patterson, S. A. Lee, and J. A. Levy (2000)
J. Gen. Virol. 81, 1261-1264
 |  Abstract »  |  Full Text »

Anti-Feline Immunodeficiency Virus (FIV) Soluble Factor(s) Produced from Antigen-Stimulated Feline CD8+ T Lymphocytes Suppresses FIV Replication.

I.-S. Choi, R. Hokanson, and E. W. Collisson (2000)
J. Virol. 74, 676-683
 |  Abstract »  |  Full Text »

The Simian Immunodeficiency Virus Envelope Glycoprotein Contains Two Epitopes Presented by the Mamu-A*01 Class I Molecule.

M. Furchner, A. L. Erickson, T. Allen, D. I. Watkins, A. Sette, P. R. Johnson, and C. M. Walker (1999)
J. Virol. 73, 8035-8039
 |  Abstract »  |  Full Text »  |  PDF »

Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus-infected Macaques.

X. Jin, D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, L. Weinberger, et al. (1999)
J. Exp. Med. 189, 991-998
 |  Abstract »  |  Full Text »  |  PDF »

Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes.

J. E. Schmitz, M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, et al. (1999)
Science 283, 857-860
 |  Abstract »  |  Full Text »

Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytotoxic anti-HIV response.

S. A. Stranford, J. Skurnick, D. Louria, D. Osmond, S.-Y. Chang, J. Sninsky, G. Ferrari, K. Weinhold, C. Lindquist, and J. A. Levy (1999)
PNAS 96, 1030-1035
 |  Abstract »  |  Full Text »  |  PDF »

Comparative Analysis of Cytotoxic T Lymphocytes in Lymph Nodes and Peripheral Blood of Simian Immunodeficiency Virus-Infected Rhesus Monkeys.

M. J. Kuroda, J. E. Schmitz, W. A. Charini, C. E. Nickerson, C. I. Lord, M. A. Forman, and N. L. Letvin (1999)
J. Virol. 73, 1573-1579
 |  Abstract »  |  Full Text »

HLA Compatibility Requirements for CD8+-T-Cell-Mediated Suppression of Human Immunodeficiency Virus Replication.

C. E. Mackewicz, M. R. Garovoy, and J. A. Levy (1998)
J. Virol. 72, 10165-10170
 |  Abstract »  |  Full Text »  |  PDF »

Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus.

M. Robert-Guroff, H. Kaur, L. J. Patterson, M. Leno, A. J. Conley, P. M. McKenna, P. D. Markham, E. Richardson, K. Aldrich, K. Arora, et al. (1998)
J. Virol. 72, 10275-10280
 |  Abstract »  |  Full Text »  |  PDF »

Natural Killer Cells from HIV-1+ Patients Produce C-C Chemokines and Inhibit HIV-1 Infection.

T. A. Fehniger, G. Herbein, H. Yu, M. I. Para, Z. P. Bernstein, W. A. O'Brien, and M. A. Caligiuri (1998)
J. Immunol. 161, 6433-6438
 |  Abstract »  |  Full Text »  |  PDF »

Virological and Immunological Features of Long-Term Human Immunodeficiency Virus-Infected Individuals Who Have Remained Asymptomatic Compared With Those Who Have Progressed to Acquired Immunodeficiency Syndrome.

E. Barker, C. E. Mackewicz, G. Reyes-Teran, A. Sato, S. A. Stranford, S. H. Fujimura, C. Christopherson, S.-Y. Chang, and J. A. Levy (1998)
Blood 92, 3105-3114
 |  Abstract »  |  Full Text »  |  PDF »

Alloantigen-Stimulated Anti-HIV Activity.

L. A. Pinto, S. Sharpe, D. I. Cohen, and G. M. Shearer (1998)
Blood 92, 3346-3354
 |  Abstract »  |  Full Text »  |  PDF »

Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection.

J. L. Fahey (1998)
Clin. Vaccine Immunol. 5, 597-603
 |  Full Text »

HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3.

F. Hadida, V. Vieillard, B. Autran, I. Clark-Lewis, M. Baggiolini, and P. Debre (1998)
J. Exp. Med. 188, 609-614
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Simian Immunodeficiency Virus (SIV) Replication by CD8+ T Lymphocytes from Macaques Immunized with Live Attenuated SIV.

M.-C. Gauduin, R. L. Glickman, R. Means, and R. P. Johnson (1998)
J. Virol. 72, 6315-6324
 |  Abstract »  |  Full Text »  |  PDF »

Recovery of the Immune System With Antiretroviral Therapy: The End of Opportunism?.

W. G. Powderly, A. Landay, and M. M. Lederman (1998)
JAMA 280, 72-77
 |  Abstract »  |  Full Text »  |  PDF »

Expression of the CD8alpha beta -Heterodimer on CD8+ T Lymphocytes in Peripheral Blood Lymphocytes of Human Immunodeficiency Virus- and Human Immunodeficiency Virus+ Individuals.

J. E. Schmitz, M. A. Forman, M. A. Lifton, O. Concepcion Jr, K. A. Reimann, C. S. Crumpacker, J. F. Daley, R. S. Gelman, and N. L. Letvin (1998)
Blood 92, 198-206
 |  Abstract »  |  Full Text »  |  PDF »

Progress in the Development of an HIV-1 Vaccine.

N. L. Letvin (1998)
Science 280, 1875-1880
 |  Abstract »  |  Full Text »

Analysis of Gag-specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus-infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I-Peptide Complex.

M. J. Kuroda, J. E. Schmitz, D. H. Barouch, A. Craiu, T. M. Allen, A. Sette, D. I. Watkins, M. A. Forman, and N. L. Letvin (1998)
J. Exp. Med. 187, 1373-1381
 |  Abstract »  |  Full Text »  |  PDF »

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA.

G. S. Ogg, X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, et al. (1998)
Science 279, 2103-2106
 |  Abstract »  |  Full Text »

Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: Implications for HIV pathogenesis.

L. Flamand, R. W. Crowley, P. Lusso, S. Colombini-Hatch, D. M. Margolis, and R. C. Gallo (1998)
PNAS 95, 3111-3116
 |  Abstract »  |  Full Text »  |  PDF »

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

I. M. Belyakov, M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, and J. A. Berzofsky (1998)
PNAS 95, 1709-1714
 |  Abstract »  |  Full Text »  |  PDF »

Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta -chemokines.

E. Barker, K. N. Bossart, and J. A. Levy (1998)
PNAS 95, 1725-1729
 |  Abstract »  |  Full Text »  |  PDF »

Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine.

L. Mortara, F. Letourneur, H. Gras-masse, A. Venet, J.-G. Guillet, and I. Bourgault-Villada (1998)
J. Virol. 72, 1403-1410
 |  Abstract »  |  Full Text »  |  PDF »

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia.

J. K. Wong, M. Hezareh, H. F. Günthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman (1997)
Science 278, 1291-1295
 |  Abstract »  |  Full Text »

HIV versus Cytotoxic T Lymphocytes -- The War Being Lost.

M. B.A. Oldstone (1997)
N. Engl. J. Med. 337, 1306-1308
 |  Full Text »

Inhibition of HIV-1 Infection by the -Chemokine MDC.

R. Pal, A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico (1997)
Science 278, 695-698
 |  Abstract »  |  Full Text »

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

O. O. Yang, A.-C. Tran, S. A. Kalams, R. P. Johnson, M. R. Roberts, and B. D. Walker (1997)
PNAS 94, 11478-11483
 |  Abstract »  |  Full Text »  |  PDF »

Safety of Autologous, Ex Vivo-Expanded Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Infusion in HIV-Infected Patients.

J. Lieberman, P. R. Skolnik, G. R. Parkerson III, J. A. Fabry, B. Landry, J. Bethel, J. Kagan, and the DATRI 006 Study Team (1997)
Blood 90, 2196-2206
 |  Abstract »  |  Full Text »  |  PDF »

Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti-Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for Antigen-Specific Immunotherapy.

G. Ferrari, C. Berend, J. Ottinger, R. Dodge, J. Bartlett, J. Toso, D. Moody, J. Tartaglia, W. I. Cox, E. Paoletti, et al. (1997)
Blood 90, 2406-2416
 |  Abstract »  |  Full Text »  |  PDF »

The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.

S. F. Lacey, C. B. McDanal, R. Horuk, and M. L. Greenberg (1997)
PNAS 94, 9842-9847
 |  Abstract »  |  Full Text »  |  PDF »

Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor.

M. Baier, N. Bannert, A. Werner, K. Lang, and R. Kurth (1997)
PNAS 94, 5273-5277
 |  Abstract »  |  Full Text »  |  PDF »

C-C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells.

A. Verani, G. Scarlatti, M. Comar, E. Tresoldi, S. Polo, M. Giacca, P. Lusso, A. G. Siccardi, and D. Vercelli (1997)
J. Exp. Med. 185, 805-816
 |  Abstract »  |  Full Text »  |  PDF »

Hemophilia and Nonprogressing Human Immunodeficiency Virus Type 1 Infection.

E. Vicenzi, P. Bagnarelli, E. Santagostino, S. Ghezzi, M. Alfano, M. S. Sinnone, G. Fabio, L. Turchetto, G. Moretti, A. Lazzarin, et al. (1997)
Blood 89, 191-200
 |  Abstract »  |  Full Text »  |  PDF »

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.

P. Klenerman, R. E. Phillips, C. R. Rinaldo, L. M. Wahl, G. Ogg, R. M. May, A. J. McMichael, and M. A. Nowak (1996)
PNAS 93, 15323-15328
 |  Abstract »  |  Full Text »  |  PDF »

CD8+ T-cell-derived soluble factor(s), but not beta -chemokines RANTES, MIP-1alpha , and MIP-1beta , suppress HIV-1 replication in monocyte/macrophages.

H. Moriuchi, M. Moriuchi, C. Combadiere, P. M. Murphy, and A. S. Fauci (1996)
PNAS 93, 15341-15345
 |  Abstract »  |  Full Text »  |  PDF »

Sensitivity to inhibition by beta -chemokines correlates with biological phenotypes of primary HIV-1 isolates.

M. Jansson, M. Popovic, A. Karlsson, F. Cocchi, P. Rossi, J. Albert, and H. Wigzell (1996)
PNAS 93, 15382-15387
 |  Abstract »  |  Full Text »  |  PDF »

Lymphocyte-Mediated Cytolysis and Disease.

C.-C. Liu, L. H.Y. Young, and J. D.-E Young (1996)
N. Engl. J. Med. 335, 1651-1659
 |  Full Text »  |  PDF »

Response: Role of beta-Chemokines in Suppressing HIV Replication.

F. Cocchi, A. L. DeVico, A. Garzino-Demo, P. Lusso, and R. C. Gallo (1996)
Science 274, 1394-1395
 |  PDF »

Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.

D. J. Blackbourn, C. E. Mackewicz, E. Barker, T. K. Hunt, B. Herndier, A. T. Haase, and J. A. Levy (1996)
PNAS 93, 13125-13130
 |  Abstract »  |  Full Text »  |  PDF »

Identification of RANTES, MIP-1alpha, and MIP-1beta as the Major HIV-Suppressive Factors Produced by CD8+ T Cells.

F. Cocchi, A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso (1995)
Science 270, 1811-1815
 |  Abstract »  |  PDF »

Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection.

Y. Cao, L. Qin, L. Zhang, J. Safrit, and D. D. Ho (1995)
N. Engl. J. Med. 332, 201-208
 |  Abstract »  |  Full Text »  |  PDF »

Infection of a Laboratory Worker with Simian Immunodeficiency Virus.

R. F. Khabbaz, W. Heneine, J. R. George, B. Parekh, T. Rowe, T. Woods, W. M. Switzer, H. M. McClure, M. Murphey-Corb, and T. M. Folks (1994)
N. Engl. J. Med. 330, 172-177
 |  Full Text »

Vaccines against Human Immunodeficiency Virus -- Progress and Prospects.

N. L. Letvin (1993)
N. Engl. J. Med. 329, 1400-1405
 |  Full Text »

HIV and AIDS.

J. Laman (1993)
Science 260, 1707-1708
 |  PDF »

Risk for Perinatal HIV-1 Transmission According to Maternal Immunologic, Virologic, and Placental Factors.

M. E. St. Louis, M. Kamenga, C. Brown, A. M. Nelson, T. Manzila, V. Batter, F. Behets, U. Kabagabo, R. W. Ryder, M. Oxtoby, et al. (1993)
JAMA 269, 2853-2859
 |  Abstract »  |  PDF »

To Advertise   |   Find Products